Karol M. Lacki is R&D staff scientist at GE Healthcare Bio-Sciences AB
Upcoming Technologies to Facilitate More Efficient Biologics Manufacturing
Choosing the right tools to enhance the process.
Technical and Economical Evaluation of Downstream Processing Options for Monoclonal Antibody (Mab) Production
Downstream process design can increase facility output through improved overall process yield or higher batch capacity in mass and volume.